13F Data
13F filer · CIK 1544773

Consonance Capital Management LP

New York, NY · filing since Q2 2013 · last filing Nov 14, 2022
Reported value
$7.3M
$-16.4M vs prior
Positions
2
New / sold out
0 / 5
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $13.0M
Top-10 weight
100.0%

Biggest buys vs Q2 2022

No new or increased positions this quarter.

Biggest sells vs Q2 2022

ChangeSecurityShares changeChange %Est. trade value
Sold outSILENCE THERAPEUTICS PLC-634,270-100.0%$-7.5M
Sold outCOMPASS THERAPEUTICS INC-1,603,789-100.0%$-4.2M
Sold outUNITED THERAPEUTICS CORP DEL-2,998-100.0%$-706.0K
Sold outGLOBUS MED INC-5,405-100.0%$-303.0K
Sold outTANDEM DIABETES CARE INC-4,294-100.0%$-254.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $281.2MQ3 2013: $399.9MQ4 2013: $610.0MQ1 2014: $672.1MQ2 2014: $672.2MQ3 2014: $728.6MQ4 2014: $776.3MQ1 2015: $1.1BQ2 2015: $995.3MQ3 2015: $710.7MQ4 2015: $745.5MQ1 2016: $660.9MQ2 2016: $706.5MQ3 2016: $1.0BQ4 2016: $910.6MQ1 2017: $954.1MQ2 2017: $848.7MQ3 2017: $904.2MQ4 2017: $1.1BQ1 2018: $1.1BQ2 2018: $1.6BQ3 2018: $1.9BQ4 2018: $1.4BQ1 2019: $1.6BQ2 2019: $1.4BQ3 2019: $1.0BQ4 2019: $1.6BQ1 2020: $1.3BQ2 2020: $1.7BQ3 2020: $820.8MQ4 2020: $1.1BQ1 2021: $938.0MQ2 2021: $830.9MQ3 2021: $182.7MQ4 2021: $153.3MQ1 2022: $58.9MQ2 2022: $23.7MQ3 2022: $7.3M
Q2 2013Q3 2022

Holdings · Q3 2022

#SecuritySharesValueWeight
1SURROZEN INCCOM3,497,500$7.1M97.05%
2SURROZEN INC*W EXP 08/01/2031,165,832$215.0K2.95%